Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
237 Leser
Artikel bewerten:
(1)

HealthSnap Receives Graphical User Interface Patent for Best in Class Remote Patient Monitoring Platform Billing Automation Feature

Finanznachrichten News

MIAMI, FL / ACCESSWIRE / April 27, 2022 / HealthSnap, a Miami-based full-service Remote Patient Monitoring (RPM) platform for virtual chronic disease management, announced today that it has been issued a Graphical User Interface (GUI) patent by the United States Patent and Trademark Office (USPTO) for its innovative and visual RPM billing technology. The patented tool is available within HealthSnap's provider portal and simplifies the Center for Medicare and Medicaid Services (CMS) billing and compliance requirements for RPM CPT codes.

"Ensuring healthcare providers recognize optimal financial outcomes with HealthSnap's RPM program is imperative to long-term sustainability. We are proud to announce this major milestone in HealthSnap's product development and look forward to continuing to support our customers in a rapidly changing reimbursement landscape," said Chase Preston, Co-Founder, and Chief Product Officer.

HealthSnap , Wednesday, April 27, 2022, Press release picture

HealthSnap's patented tool helps to automate tasks required to successfully document and receive reimbursement for RPM, such as patient enrollment workflows, clinical documentation automation, and visual CPT Code eligibility reporting, all of which enable providers to spend less time on compliance and clerical work and more time on providing patient care.

The company's patent, received during Q1-22, is for HealthSnap's visual billing automation feature, or "Eligibility Report," which displays a breakdown of each patient and the CPT codes eligible for RPM billing. This patent extends not only to RPM but to other codes as well including Chronic Care Management (CCM) billing codes. This newly patented tool was specifically designed to make it easy for healthcare providers to stay compliant with CMS guidelines to ensure seamless billing.

"This milestone marks HealthSnap's commitment to being a leader in virtual care management, and further sets the company apart as a best in class digital health platform serving the healthcare provider market. HealthSnap aims to make RPM and CCM simple, profitable, and scalable so that healthcare providers are able to provide virtual chronic disease management to patients, with long-term sustainability in mind," said Samson Magid, Co-Founder, and CEO.

HealthSnap provides virtual care management solutions that help healthcare providers manage chronic conditions such as hypertension, diabetes, and heart failure virtually by combining the power of an integrated care management platform that supports RPM and Chronic Care Management (CCM) programs, pre-configured and cellular-enabled health devices, and patient care management services all in one end-to-end solution.

By providing full-service care management tools and services, HealthSnap provides a care delivery paradigm that is proactive, ongoing, and delivered in the home - where chronic conditions take place. As a result, HealthSnap has been able to demonstrate improved patient outcomes, decreased utilization, and marked improvements in the overall patient experience. To date, HealthSnap has contracted with over 100 physician groups, including top 10 health systems, Federally Qualified Health Centers (FQHCs), and Independent Physician Groups (IPAs).

About HealthSnap

HealthSnap is an integrated Virtual Care Platform that helps healthcare organizations improve patient outcomes, reduce utilization, and diversify revenue streams. From chronic disease-agnostic Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) to AI-guided care coordination, virtual care delivery, automated RPM billing, population analytics - and so much more, HealthSnap is the simplest way to manage chronic conditions remotely.

Visit www.healthsnap.io or follow us on LinkedIn for more information.

Contact:
Sunny Ghia
sunny@healthsnap.io
610-442-4463

SOURCE: HealthSnap



View source version on accesswire.com:
https://www.accesswire.com/698791/HealthSnap-Receives-Graphical-User-Interface-GUI-Patent-for-Best-in-Class-Remote-Patient-Monitoring-Platform-Billing-Automation-Feature

© 2022 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.